Search clinical trials for: Suvorexant 0mg

Total 12904 results

South China Center For Innovative Pharmaceuticals
Xiangya Hospital of Central South University

Completed

Safety, Tolerability and Pharmacokinetics of AD16 Tablets in Adult Healthy Subjects After Single Administration (AD16)

Alzheimer's Disease

China
Genor Biopharma Co., Ltd.

Unknown

Phase Ⅰ Clinical Trial of Gerilimzumab Injection in Healthy Subjects

Rheumatoid Arthritis

China
The University of Texas Health Science Center,...

Recruiting

Suvorexant to Reduce Symptoms of Nicotine Use

Smoking Cessation

United States
GlaxoSmithKline

Completed

A Comparison of Atorvastatin and Glimepiride Fixed Dose Combination and Atorvastatin and Glimepiride Loose Combination in the Treatment of Patients With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2

Korea, Republic of, Malaysia, Philippines, Thailand, Russian Federation, Mexico
Henry Ford Health System

Completed

Study to Compare the Awakening Threshold Effects of Belsomra 10 mg and 20 mg to Placebo in Non-elderly Insomniacs

Insomnia

United States
EnnovaBio Australia Pharmaceuticals Pty Ltd

Completed

A First-in-human Single Ascending Dose/Multiple Ascending Dose Study of ENN0403 in Healthy Subjects

Healthy

Australia
Lee's Pharmaceutical Limited

Completed

A Study to Evaluate the Safety and Tolerability of Tecarfarin in Healthy Chinese Volunteers

Pharmacokinetic and Pharmacodynamic Profile of Tecarfarin

Hong Kong
GlaxoSmithKline

Completed

A Study in Asthmatics to Determine the Efficacy and Dose Response of Repeat Doses of GW870086X on Forced Expiratory Volume in 1 Second (FEV1)

Asthma

Germany, South Africa, Bulgaria
Eisai Co., Ltd.

Completed

A Single-dose Study in Healthy Japanese Male Adults to Evaluate Pharmacokinetics and Pharmacodynamics of E5501 5 mg Tablet (Study E5501-J081-015)

Healthy

Japan
Mclean Hospital

Recruiting

Targeting Orexin to Treat Nicotine Dependence

Nicotine Dependence

United States
J2H Biotech

Completed

Phase 1 Study to Investigate Safety, Tolerability, PK/PK of J2H-1702 in Healthy Males

Non-alcoholic Steatohepatitis

Korea, Republic of
Linda Van Eldik
National Institute on Aging (NIA); Duke Clinical Research Institute

Completed

MW151-101: First-in-human Study of MW151

Drug Toxicity

United States
Cephalon

Completed

Study of the Efficacy, Safety and Tolerability of Oral CEP-701 in Patients With Severe Psoriasis

Psoriasis

United States
University of Edinburgh
NHS Lothian

Completed

Cardiovascular Effects of Apelin In Healthy Volunteers

Healthy

United Kingdom
Novartis Pharmaceuticals

Terminated

A Study to Assess the Safety and Efficacy of ZPL389 in Patients With Moderate to Severe Atopic Dermatitis

Atopic Dermatitis

United States, United Kingdom, Germany, Hungary, Russian Federation, Taiwan, Belgium, Netherlands, Japan, Austria, Finland, Slovakia, Czechia, Canada, Iceland, Poland
International AIDS Vaccine Initiative
Beth Israel Deaconess Medical Center; Ragon Institute of MGH, MIT and Harvard; University of Texas Health, Houston AIDS Research Team (HART) and other collaborators

Completed

A Clinical Trial of PGDM1400 and PGT121 and VRC07-523LS Monoclonal Antibodies in HIV-infected and HIV-uninfected Adults

HIV Infections

United States
E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd.

Not yet recruiting

A Study of QY201 Tablet in Subjects With Moderate to Severe Atopic Dermatitis

Atopic Dermatitis
Medicines for Malaria Venture
University of Cape Town

Completed

Phase I Study of Ascending Doses of MMV390048 in Healthy Adult Volunteers

Malaria

South Africa
The University of Texas Health Science Center,...
Peter F. McManus Charitable Trust

Completed

Role of the Orexin Receptor System in Stress, Sleep and Cocaine Use

Anxiety | Cocaine Use Disorder

United States
Taisho Pharmaceutical Co., Ltd.

Completed

A Phase 2 Dose-finding Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis

Hyperphosphatemia Patients on Hemodialysis

Japan
Otsuka Pharmaceutical Co., Ltd.

Recruiting

A Dose-ranging Trial of OPC-131461 in Cardiac Edema (Congestive Heart Failure [CHF])

Cardiac Edema (CHF)

Japan
Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Completed

Medical Management of Sleep Disturbance During Opioid Tapering

Sleep Disturbance | Opioid Dependence | Opioid Withdrawal

United States
Duke University
Merck Sharp & Dohme LLC

Recruiting

REPOSE Study: Reducing Delirium by Enhancing Postoperative Sleep With Suvorexant (REPOSE)

Delirium in Old Age

United States
Merck Sharp & Dohme LLC

Completed

Safety and Efficacy Study of Suvorexant in Participants With Primary Insomnia - Study B (MK-4305-029)

Primary Insomnia
Merck Sharp & Dohme LLC

Completed

Safety and Efficacy Study of Suvorexant in Participants With Primary Insomnia - Study A (MK-4305-028)

Primary Insomnia
The Florey Institute of Neuroscience and Mental...
Melbourne Health; St Vincent's Hospital Melbourne

Terminated

Suvorexant in the Management Comorbid Sleep Disorder and Alcohol Dependence

Insomnia | Alcohol Use Disorder

Australia
Milton S. Hershey Medical Center

Completed

The Efficacy of Suvorexant in Treatment of Patients With Substance Use Disorder and Insomnia: A Pilot Open Trial (Suvsubuse)

Sleep Disturbance | Craving | Cortisol; Hypersecretion

United States
Hanmi Pharmaceutical Company Limited

Completed

Efficacy/Safety of HCP1306 Tablet Versus HGP0816 Tablet in Patients With Primary Hypercholesterolemia

Primary Hypercholesterolemia

Korea, Republic of
Beth Israel Deaconess Medical Center
Merck Sharp & Dohme LLC

Recruiting

Suvorexant and Sleep/Delirium in ICU Patients

Insomnia | Sleep Initiation and Maintenance Disorders | Postoperative Delirium | Sleep Fragmentation

United States
Helixmith Co., Ltd.

Completed

Safety Study of Gene Therapy in Treating Lower Leg Ischemia

Critical Limb Ischemia

United States
Kyowa Kirin Co., Ltd.
Kyowa Hakko Kirin China Pharmaceutical Co., LTD.

Completed

Pharmacokinetic Study of KHK7580 in Healthy Adult Volunteers

Healthy Volunteer

China
The Scripps Research Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Medication Development in Alcoholism: Suvorexant Versus Placebo

Alcohol Use Disorder (AUD)

United States
Washington University School of Medicine
Merck Sharp & Dohme LLC; Good Ventures Foundation

Recruiting

Sleep Trial to Prevent Alzheimer's Disease (SToP-AD)

Sleep | Alzheimer Disease

United States
Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Recruiting

Measuring Acute Drug Demand in Humans

Opioid Use Disorder | Opioid Dependence

United States
Howard University
National Institute of Mental Health (NIMH); Georgetown-Howard Universities...

Completed

Suvorexant and Sleep's Benefits to Therapeutic Exposure for Posttraumatic Stress Disorder

Posttraumatic Stress Disorder

United States
Cephalon

Completed

Open Study of CEP-701 in Patients With Refractory Acute Myeloid Leukemia With FLT-3 Mutation

Leukemia, Myeloid
BeBetter Med Inc

Completed

Study of Orally Administered BEBT-503 in Healthy Subjects

Healthy Subjects

Australia
Walter Reed Army Institute of Research (WRAIR)

Enrolling by invitation

A Comparison of the Physiological and Behavioral Effects of Suvorexant and Zolpidem in Healthy Volunteers: A Randomized, Double-blind, Placebo Controlled Study

Performance Enhancing Product Use

United States
Massachusetts General Hospital

Withdrawn

Suvorexant (Belsomra) for the Treatment of Bipolar Depression With Insomnia

Insomnia | Bipolar Disorder
Jichi Medical University
Merck Sharp & Dohme LLC; Satt Co.,Ltd

Completed

To Compare the Effectiveness of Suvorexant vs Placebo on Sleep Pressure in Hypertensives With Insomnia (Super1)

Hypertension | Insomnia

Japan
Mitsubishi Tanabe Pharma America Inc.

Completed

MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women

Menopause Hot Flashes

United States
Howard University
Merck Sharp & Dohme LLC

Completed

Suvorexant and Trauma Related Insomnia

Insomnia | Posttraumatic Stress Disorder

United States
Brigham and Women's Hospital

Completed

Efficacy of Suvorexant in the Treatment of Hot Flash-associated Insomnia

Insomnia

United States
University of California, San Francisco

Completed

The Role of Orexin in Human Panic Disorder

Panic Disorder

United States
Institute for Advanced Medical Research, Alpharetta...
Augusta University, Dept. of Psychiatry

Unknown

A Six Week, Randomized, Double-Blind Placebo-Controlled, Suvorexant Augmentation Study of Antidepressant Treatment of Major Depressive Disorder With Residual Insomnia

Depression | Insomnia | Major Depressive Disorder | MDD

United States
Merck Sharp & Dohme LLC

Completed

Phase IIB 2-Period Crossover Polysomnography Study in Participants With Primary Insomnia (MK-4305-006)

Primary Insomnia
Merck Sharp & Dohme LLC

Completed

A Long Term Safety Study of Suvorexant in Participants With Primary Insomnia (MK-4305-009 AM3)

Insomnia
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Recruiting

A Study of HS-20094 in T2DM Participants

Type 2 Diabetes

China
Hanmi Pharmaceutical Company Limited

Completed

Duration of P-glycoprotein Inhibition After Oral Administration of HM30181AK Tablet (PGP inhibitor)

Healthy

Korea, Republic of
Can-Fite BioPharma

Completed

Safety and Efficacy Study of CF101 to Treat Psoriasis

Plaque Psoriasis

Israel

Search clinical trials for: Suvorexant 0mg

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Equatorial Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations